Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

F Wu, J Yang, J Liu, Y Wang, J Mu, Q Zeng… - … and Targeted Therapy, 2021 - nature.com
To flourish, cancers greatly depend on their surrounding tumor microenvironment (TME),
and cancer-associated fibroblasts (CAFs) in TME are critical for cancer occurrence and …

Primary and metastatic peritoneal surface malignancies

D Cortés-Guiral, M Hübner, M Alyami, A Bhatt… - Nature Reviews …, 2021 - nature.com
Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

P Baas, A Scherpereel, AK Nowak, N Fujimoto… - The Lancet, 2021 - thelancet.com
Background Approved systemic treatments for malignant pleural mesothelioma (MPM) have
been limited to chemotherapy regimens that have moderate survival benefit with poor …

A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti–PD-1 agent pembrolizumab

PS Adusumilli, MG Zauderer, I Rivière, SB Solomon… - Cancer discovery, 2021 - AACR
Malignant pleural diseases, comprising metastatic lung and breast cancers and malignant
pleural mesothelioma (MPM), are aggressive solid tumors with poor therapeutic response …

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

T Liu, C Han, S Wang, P Fang, Z Ma, L Xu… - Journal of hematology & …, 2019 - Springer
Among all the stromal cells that present in the tumor microenvironment, cancer-associated
fibroblasts (CAFs) are one of the most abundant and critical components of the tumor …

Turning foes to friends: targeting cancer-associated fibroblasts

X Chen, E Song - Nature reviews Drug discovery, 2019 - nature.com
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …

Fibroblasts in cancer: Unity in heterogeneity

Y Chhabra, AT Weeraratna - Cell, 2023 - cell.com
Tumor cells do not exist in isolation in vivo, and carcinogenesis depends on the surrounding
tumor microenvironment (TME), composed of a myriad of cell types and biophysical and …

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

D Fukumura, J Kloepper, Z Amoozgar… - Nature reviews Clinical …, 2018 - nature.com
Immunotherapy has emerged as a major therapeutic modality in oncology. Currently,
however, the majority of patients with cancer do not derive benefit from these treatments …

Perspectives on the treatment of malignant pleural mesothelioma

SM Janes, D Alrifai, DA Fennell - New England Journal of …, 2021 - Mass Medical Soc
Mesothelioma Most mesotheliomas originate in the pleura and are due to asbestos
exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality …

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

M Carbone, PS Adusumilli… - CA: a cancer journal …, 2019 - Wiley Online Library
Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …